Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03595917 |
|---|---|
| Brief Title: | ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML |
| First Submitted : | July 12, 2018 |
| First Submitted that Met QC Criteria : | July 12, 2018 |
| First Posted : | July 23, 2018 |
| Last Update Submitted that Met QC Criteria : | December 4, 2023 |
| Last Update Posted : | December 5, 2023 |